SINGULEX, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • October 17th, 2012 • Singulex Inc • Services-medical laboratories • Delaware
Contract Type FiledOctober 17th, 2012 Company Industry JurisdictionThis Indemnification Agreement (this “Agreement”) is effective as of [·] by and between Singulex, Inc., a Delaware corporation (the “Company”), and «Indemnitee» (“Indemnitee”).
SINGULEX, INC. 2012 EQUITY INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE AND STOCK OPTION AGREEMENTStock Option Agreement • October 17th, 2012 • Singulex Inc • Services-medical laboratories • Delaware
Contract Type FiledOctober 17th, 2012 Company Industry JurisdictionSingulex, Inc., a Delaware corporation (the “Company”), pursuant to its 2012 Equity Incentive Award Plan (the “Plan”), hereby grants to the individual listed below (the “Optionee”), an option to purchase the number of shares of the common stock of the Company (“Shares”), set forth below (the “Option”). This Option is subject to all of the terms and conditions set forth herein and in the Agreement attached hereto as Exhibit A (the “Agreement”) and the Plan, which are incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Grant Notice and the Agreement.
LOAN AND SECURITY MODIFICATION AGREEMENTLoan and Security Modification Agreement • October 17th, 2012 • Singulex Inc • Services-medical laboratories
Contract Type FiledOctober 17th, 2012 Company IndustryThis Loan and Security Modification Agreement is entered into as of March 18, 2008, by and between Singulex, Inc. (the “Borrower”) and Bridge Bank, National Association (“Lender”).
SINGULEX, INC. BRIDGE BANK, N.A. AMENDED AND RESTATED LOAN AND SECURITY AGREEMENTLoan and Security Agreement • October 17th, 2012 • Singulex Inc • Services-medical laboratories • California
Contract Type FiledOctober 17th, 2012 Company Industry JurisdictionThis AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT is entered into as of May 15, 2007, by and between BRIDGE BANK, N.A. (“Bank”) and SINGULEX, INC. (“Borrower”).
WARRANT TO PURCHASE SECURITIES OF SINGULEX, INC. Void after September 1, 2016Warrant Agreement • October 17th, 2012 • Singulex Inc • Services-medical laboratories • Missouri
Contract Type FiledOctober 17th, 2012 Company Industry JurisdictionThis Warrant is issued to General Electric Capital Corporation, a Delaware corporation, or its registered assigns (the “Holder”) by Singulex, Inc., a Delaware corporation (the “Company”), on October 12, 2006 (the “Warrant Issue Date”) in connection with the Company and the Holder entering into that certain Master Security Agreement, dated as of September 14, 2006 (the “Security Agreement”).
WARRANT TO PURCHASE SECURITIES OF SINGULEX, INC. Void after April , 2014Warrant Agreement • October 17th, 2012 • Singulex Inc • Services-medical laboratories • Missouri
Contract Type FiledOctober 17th, 2012 Company Industry JurisdictionThis Warrant is issued to , or its registered assigns (the “Holder”) by Singulex, Inc., a Delaware corporation (the “Company”), on April , 2007 (the “Warrant Issue Date”) in connection with the issuance of the Convertible Promissory Note, dated as of the Warrant Issue Date, in the original stated principal amount of $ , by the Company to the Holder (the “Note”). The Note and the Convertible Promissory Note issued by the Company on the Warrant Issue Date to constitute a single series of Convertible Promissory Notes (collectively, the “Bridge Notes”). The Company hereby covenants that each warrant issued in connection with any such other Bridge Note shall be identical to this Warrant except as to the purchaser thereunder and the amount of the Company’s securities that is the subject of such warrant, provided that the amount of such securities is determined pursuant to a formula identical to the formula set forth in this Warrant.
ContractWarrant Agreement • October 17th, 2012 • Singulex Inc • Services-medical laboratories • Delaware
Contract Type FiledOctober 17th, 2012 Company Industry JurisdictionTHIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii)AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF THIS WARRANT.
LOAN AND SECURITY MODIFICATION AGREEMENTLoan and Security Modification Agreement • October 17th, 2012 • Singulex Inc • Services-medical laboratories
Contract Type FiledOctober 17th, 2012 Company IndustryThis Loan and Security Modification Agreement is entered into as of July 29, 2009, by and between Singulex, Inc. (the “Borrower”) and Bridge Bank, National Association (“Lender”).
LOAN AND SECURITY MODIFICATION AGREEMENTLoan and Security Modification Agreement • October 17th, 2012 • Singulex Inc • Services-medical laboratories
Contract Type FiledOctober 17th, 2012 Company Industry
SINGULEX, INC. STOCK PURCHASE WARRANT NO. W-Warrant Agreement • October 17th, 2012 • Singulex Inc • Services-medical laboratories • Delaware
Contract Type FiledOctober 17th, 2012 Company Industry JurisdictionThis Warrant (the “Warrant”) is being issued pursuant to the terms of that certain Bridge Loan Agreement, dated as of May 6, 2011 by and among the Holder, the Company and certain other investors set forth therein (the “Loan Agreement”). This Warrant may be exercised in whole or in part, at the option of the Holder. Unless otherwise defined herein, defined terms in this Warrant shall have the meanings ascribed to them in the Loan Agreement. If the Notes issued to the original Holder on the date hereof are converted into New Preferred Stock of the Company (as defined in the Loan Agreement), this Warrant shall be exercisable for a number of shares of New Preferred Stock determined as follows: the quotient of numerator (A) the product of (x) 0.25 and (y) the applicable Loan Amount loaned by such Investor at the Closing at which this Warrant was issued, and denominator (B) the lowest per share price for which any person or
AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENTLoan and Security Agreement • October 17th, 2012 • Singulex Inc • Services-medical laboratories
Contract Type FiledOctober 17th, 2012 Company IndustryThis Amendment to Amended and Restated Loan and Security Agreement is entered into as of May 27, 2010 (the “Amendment”), by and between BRIDGE BANK, NATIONAL ASSOCIATION (“Bank”) and SINGULEX, INC. (“Borrower”).
LOAN AND SECURITY MODIFICATION AGREEMENTLoan and Security Modification Agreement • October 17th, 2012 • Singulex Inc • Services-medical laboratories
Contract Type FiledOctober 17th, 2012 Company IndustryThis Loan and Security Modification Agreement (this “Loan and Security Modification Agreement”) is entered into as of September 26, 2012 by and between Singulex, Inc. (the “Borrower”) and Bridge Bank, National Association (“Bank”).
ContractWarrant Agreement • October 17th, 2012 • Singulex Inc • Services-medical laboratories • Delaware
Contract Type FiledOctober 17th, 2012 Company Industry JurisdictionTHIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OR SUCH STATE SECURITIES LAWS OR UNLESS SOLD PURSUANT TO RULE 144 UNDER THE SECURITIES ACT.
LOAN AND SECURITY MODIFICATION AGREEMENTLoan and Security Modification Agreement • October 17th, 2012 • Singulex Inc • Services-medical laboratories
Contract Type FiledOctober 17th, 2012 Company IndustryThis Loan and Security Modification Agreement is entered into as of June 25, 2012, by and between Singulex, Inc. (“Borrower”) and Bridge Bank, National Association (“Bank”).
TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENTLoan and Security Agreement • October 17th, 2012 • Singulex Inc • Services-medical laboratories
Contract Type FiledOctober 17th, 2012 Company IndustryThis Amendment to Amended and Restated Loan and Security Agreement is entered into as of November 23, 2010 (the “Amendment”), by and between BRIDGE BANK, NATIONAL ASSOCIATION (“Bank”) and SINGULEX, INC. (“Borrower”).
AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENTLoan and Security Agreement • October 17th, 2012 • Singulex Inc • Services-medical laboratories
Contract Type FiledOctober 17th, 2012 Company IndustryThis Amendment to Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into as of November 30, 2009, by and between BRIDGE BANK, NATIONAL ASSOCIATION (“Bank”) and SINGULEX, INC. (“Borrower”).
AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENTLoan and Security Agreement • October 17th, 2012 • Singulex Inc • Services-medical laboratories
Contract Type FiledOctober 17th, 2012 Company IndustryThis Amendment to Amended and Restated Loan and Security Agreement is entered into as of October 8, 2010 (the “Amendment”), by and between BRIDGE BANK, NATIONAL ASSOCIATION (“Bank”) and SINGULEX, INC. (“Borrower”).